Axsome Therapeutics
Axsome Therapeutics (NASDAQ: AXSM) is a biopharmaceutical company developing and delivering novel therapies for the management of central nervous system (CNS) disorders. Headquartered at One World Trade Center, New York, Axsome markets three FDA-approved products — Auvelity (dextromethorphan-bupropion) for major depressive disorder, Sunosi (solriamfetol) for excessive daytime sleepiness in narcolepsy and obstructive sleep apnea, and Symbravo (meloxicam-rizatriptan) for the acute treatment of migraine — and is advancing a pipeline including AXS-05 for Alzheimer's disease agitation and smoking cessation, AXS-12 (reboxetine) for narcolepsy, and AXS-14 (esreboxetine) for fibromyalgia. Axsome operates a corporate website and product / HCP microsites but does not expose a public developer API surface; this profile catalogs corporate, product, regulatory, and investor touchpoints rather than programmatic interfaces.
More than an index entry, but the surface is still mostly links rather than artifacts — the cohort most likely to move a full band from modest, well-targeted work.
API Evangelist profiles Axsome Therapeutics the way a machine reads it — 19 machine-readable artifacts, pulled from the provider's own public surface and indexed so a developer, an analyst, or an AI agent can evaluate it against every other provider on the network.
Every provider in the network is reduced to the same set of machine-readable artifacts — OpenAPI contracts, event specifications, GraphQL schemas, runnable collections, pricing and rate-limit signals, security posture, OAuth scopes, and the agent surfaces (MCP servers and skills) that let software drive the API on its own. We profile them because the interface is the part of a company you can actually inspect: it is a truer signal of what a provider does than any marketing page. From those artifacts we compute the Kin Score — Axsome Therapeutics scores 21.3/100 (emerging), with a separate agent-readiness read of 0/100 (human only). The full breakdown is below, followed by every artifact we hold — each card links through to its machine-readable definition on apis.io.
Kin Score
This is the API Evangelist rating — a single, repeatable read computed from the artifacts on this page. Green fill is points earned; the red track is points possible, so every bar shows earned-versus-possible at a glance.
Kin Score
How this is scored →scored 2026-07-27 · rubric v0.5
How we profile Axsome Therapeutics
Each block below is one kind of artifact we hold for Axsome Therapeutics. For each we say what it is and why it earns a place in the profile, then list every one we've indexed — capped at two rows, scroll within the panel for the rest.
Features 6
The notable capabilities this provider advertises, captured as structured features so they can be searched and compared instead of read one landing page at a time.
Notable capabilities this provider offers.
CNS Therapeutic Focus
Exclusive focus on central nervous system disorders spanning psychiatric, neurologic, and sleep-wake conditions.
Multi-Mechanistic Small Molecules
Portfolio leverages combinations and single enantiomers acting on NMDA, sigma-1, monoamine reuptake, TAAR1, 5-HT, and GABA targets.
Commercial Stage with Three Approved Products
Auvelity, Sunosi, and Symbravo are commercially marketed in the United States with sales force and patient support infrastructure.
Active Late-Stage Pipeline
Pipeline candidates AXS-05, AXS-12, and AXS-14 address Alzheimer's disease agitation, narcolepsy, fibromyalgia, and smoking cessation.
Investor Disclosure
Quarterly earnings, SEC filings (10-K, 10-Q, 8-K), webcasts, presentations, and analyst coverage published on the corporate site and EDGAR.
Medical Information Services
U.S. and Canada medical-information request channels for healthcare professionals and patients.
Semantic Vocabularies 1
JSON-LD contexts give the data shared meaning across APIs. We profile them because semantics are what let a machine reconcile 'customer' here with 'customer' somewhere else.
JSON-LD contexts and semantic vocabularies used across these APIs.
Axsome Therapeutics Context
JSON-LDSecurity Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals — the evidence that a provider takes security seriously enough to document it. We profile it because you can't govern what you can't see.
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Use Cases 5
What developers actually build with this provider — captured so the catalogue answers 'what is this for', not just 'what does this expose'.
What developers build with this provider.
Healthcare Professional Prescribing
HCP microsites for each marketed product provide prescribing information, dosing, safety, and access support.
Patient Access and Adherence
Patient-facing brand sites with medication guides, copay assistance, and condition education.
Investor Relations
Public disclosures, regulatory filings, and press releases for shareholders, analysts, and financial-data consumers.
Scientific Communication
Publications, congress presentations, and medical-affairs touchpoints for the clinical and scientific community.
Clinical Trial Engagement
Expanded Access Policy and trial-related communications for investigators and patients seeking access to investigational therapies.
Integrations 6
Pre-built integrations with other platforms tell you where this provider already fits in a stack.
Pre-built integrations with other platforms and tools.
U.S. Food and Drug Administration (FDA)
Regulatory submissions and approvals for NDA, sNDA, and post-marketing commitments covering Auvelity, Sunosi, Symbravo, and AXS-05.
European Medicines Agency (EMA)
Sunosi (solriamfetol) maintains EMA authorization with SmPC and PIL published on the EMA website.
Health Canada
Sunosi (solriamfetol) is approved in Canada with English and French product monographs and prescribing information.
NASDAQ / U.S. SEC
Listed on NASDAQ as AXSM; periodic and current reports filed via EDGAR.
Specialty Pharmacy Networks
U.S. distribution of branded CNS therapies through specialty and retail pharmacy partners.
Patient Support and Copay Programs
Brand-specific patient support, copay assistance, and access services delivered via HCP and patient microsites.
Resources
Every other property we hold for Axsome Therapeutics — documentation, portals, status pages, policies, and corporate surface — grouped by the job it does, following the integrator's arc from getting started to running in production.
Design & Contract 2
Pagination, idempotency, versioning, errors, and events
Access & Security 2
Authentication, authorization, and security posture
Operate 1
Status, limits, changes, and where to get help
Commercial 2
Pricing, plans, and the legal terms of use
Company 6
The organization behind the API
Other 17
Properties that don't map to a standard resource type
Scroll within the panel for all 17 ·
← All providers · Data indexed from github.com/api-evangelist/axsome-therapeutics · machine-readable index on apis.io